Julie Russo • May 1, 2023
Volunteer!


Volunteers significantly contribute to the success of the Hypertrophic Cardiomyopathy
Association and our commitment to providing support, education, advocacy, and
advancement of research, understanding, and care to those with HCM. Our volunteer’s
tireless dedication gives an extra hand needed to make our communities healthcare
experiences positive. To learn more about HCMA volunteer opportunities and get
involved, click here.

HCMA Volunteer GEM Awards Program
Please remember to log your volunteer hours regularly to participate in our Volunteer
GEM Awards (VGA) program and be recognized at the end of the year with fun prizes
and other forms of appreciation. Click GEM to learn more about our HCMA Volunteer
GEM Awards Program and how you can get involved.

Share Your Story (SYS)
HCMA Theme of the Month Stories
One of HCMA’s themes for the month of May is Medical Management: what’s New,
what’s old and what works,” featuring the story of Joseph Caruso.
If you want to share your HCM story, please email  julie@4hcm.org  to schedule an
interview. Patient stories are essential to help educate and spread awareness about
HCM!

HCMA Ambassador Program
We are reviewing the applications we have received for our HCMA Ambassador
Program’s inaugural class of 2023. Selected candidates will participate in a workshop
designed to develop best practices for optimizing your social media feed to raise
awareness of HCM through storytelling on various social medial platforms. They will
learn to educate their audience using the HCMAs repository of accurate information to
ensure HCM public awareness is factual and sound. To apply to share your HCM
experience via social media as an HCMA Ambassador, click here.

Legislative Advocacy
We have some new faces at the HCMA, our Summer 2023 interns! Each of our interns
possess the education, experience, and enthusiasm needed to succeed in helping us
move forward with the introduction and passing of the Healthy Cardiac Monitoring Act in
each state.

Healthy Cardiac Monitoring Act (HCM Act)
Our interns and volunteers have been working hard to set appointments and meet with
legislators in Ohio and Connecticut. They aim to gain support and obtain a bill
number as the next step to passing the HCM Act into law in these states. You can help
us introduce the HCM Act in your state right now! It only takes a few clicks to get the
message about the HCM Act to your state legislators to help save lives. Click here to
contact your state representatives and show your support for the HCM Act (please,
share this link with others too!!)


To view the HCM Act proposed legislation, click the following link: Health Cardiac Monitoring Act – Hypertrophic Cardiomyopathy Association ( 4hcm.org )

HCM Awareness Day Resolution/Proclamation:

The HCMA and Bristol Myers Squibb have partnered for a legislative initiative to designate the fourth Wednesday in February each year as Hypertrophic Cardiomyopathy Awareness Day in every state.

These resolutions/proclamations will support our efforts to educate people about
hypertrophic cardiomyopathy.

**State by state, as we progress with these efforts, we will reach out to our
volunteers to help champion these efforts in their home state.
If you want to volunteer for our legislative advocacy group, click the link:
https://bit.ly/3DNBKJI. Under Elizabeth T. McNamee, LEGISLATIVE ADVOCACY VOLUNTEER GROUP

Free Online Patient Discussion Groups
Our online discussion group meetings are recurring, but you must register for each
meeting date. Our meeting dates, times, and topics are updated regularly, so check our
event calendar regularly to join a meeting (or more than one) best suited for you!
UPDATE: Our “Newly Diagnosed/New to the HCMA” online education sessions will now
be held three times monthly, at various times, for even more opportunities to join a
meeting.

To view our event calendar for meeting dates and times, please click the following link:
Patient Discussion Groups – Hypertrophic Cardiomyopathy Association ( 4hcm.org )

If you have any questions about our volunteer projects, you can reach Julie Russo via
email at  julie@4hcm.org. We truly appreciate the generous people who donate
their time and talent to advocate for and support our community.

HCMA Blog

Medical Management May

April 30, 2025
Medical Management means using medicines and other non-invasive therapies to relieve symptoms. It's exciting that new treatments for HCM are being studied and that the FDA approved Camzyos in 2022! HCM can cause various symptoms depending on how stiff the heart is, how much scarring (fibrosis) there is, and whether there is obstruction. Some people have no noticeable symptoms. Common symptoms are chest pain/pressure, shortness of breath, lightheadedness, fatigue, palpitations, and brain fog. Syncope (fainting) is dramatic but not as common as the other symptoms. Medications are the first-line treatment for symptoms of HCM. If patients can't take one class of medication, they can try a medication from a different class. Here are some medications used to treat HCM and what they're for: Beta Blockers - make your heart beat slower and relax better. They allow the heart to fill more completely between beats. They can lower blood pressure and relieve symptoms. Calcium Channel Blockers - used to lower blood pressure and slow the heart rate. May reduce symptoms from obstruction in HCM. Myosin Inhibitors - cause the heart to beat with less force. They may reduce obstruction and septal thickness in some patients. Camzyos (mavacamten) is the first of this class of medication. For more information, click HERE . Antiarrhythmics - help to restore normal rhythm in the heart. Blood Thinners - anticoagulants and anti-platelets make it harder for blood to clot. They are prescribed to reduce the risk of stroke. This risk is higher in patients with afib, aflutter, and artificial heart valves. Diuretics , or "water pills," help the kidneys get rid of extra water and salt, reducing swelling in the body. Sodium Channel Blockers - may reduce gradient in obstructive HCM and can treat chest pain. Some also act as antiarrhythmics. Antibiotics - treat or prevent bacterial infections. In HCM, they may be given before dental work to prevent infective endocarditis. To learn more and see the side effects of these medications, click HERE .
On a green background, a line drawing of a head that has complicated arrows pointing outwards

Decisions in HCM: Why are they so hard?

By Gordon Fox • April 25, 2025
Part 2 of a series on making decisions in HCM. A key reason is that decision making is so difficult is that most decisions involve more than one risk.
Hypertrophic Obsctructive Cardiomyopathy

Camzyos® receives manufacturing and marketing approval for HOCM in Japan

By Erica Friedman • April 22, 2025
Bristol Myers Squibb announces that Camzyos has been approved for Obstructive Hypertrophic Cardiomyopathy in Japan.
More Posts